An example can be seen in hereditary breast cancer whereby the demand for genetic testing to predict hereditary risks is increasing since the discovery of BRCA1 and BRCA2 genes as breast cancer susceptibility genes, which account for 5%–10% of hereditary breast cancer cases (Miki et al., 1994; Wooster et al., 1994). This evidence concerns the gene BRCA2 and breast carcinoma.